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is time to promote the use of the 0/1-hour algorithm to
lessen ED congestion and reduce the risk of nosocomial
coronavirus disease 2019 infection.
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In reply:
We thank Chiang et al1 for their meta-analysis and
resulting recommendation for the global use of the European
Society of Cardiology (ESC) 0/1-hour algorithm for the rapid
assessment of patients presenting to the emergency
department (ED) with symptoms suspicious for acute
myocardial infarction and also for its update that has
incorporated the results of the High Sensitivity Cardiac
Troponin I in the United States study.2 Although we agree
with the overall recommendation that the use of the ESC 0/1-
hour algorithm for the rapid assessment of patients presenting
with symptoms suspicious for acute myocardial infarction
should be more broadly implemented in the ED in countries
around the world, we suggest some precautions. Data from
Europe, the United States, Australasia,1 and South America3
support the overall use of this ESC algorithm. However, there
is no information available about how it might perform in
other individuals (race, size, diet, comorbidities, etc) such as
those in Asia, India, andAfrica. In these other populations, the
ESC algorithm should be the preferred one used until further
studies are completed and the algorithm is either validated or
an alternative one recommended.
We report, as others have, that the ESC high sensitivity
cardiac troponin I acute myocardial infarction rule-out cut
points are also applicable to many subgroups of patients
presenting to the ED, including those with symptoms onset
in less than or equal to 3 hours. However, we do not know
whether outcomes will be the same for patients presenting to
the EDwith even shorter symptoms onset (1 hour) because
few of these patients have been studied. Consequently, in our
opinion, it remains prudent to consider a third high
sensitivity cardiac troponin I test later for the rule-out of acute
myocardial infarction in these very early presenters until more
data concerning this patient population are available.
The good news is that using the ESC 0/1-hour acute
myocardial infarction assessment algorithm in the
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coronavirus disease 2019 era to rule out cardiac injury should
decrease ED congestion, given its high negative predictive
and sensitivity values for acute myocardial infarction rule-
out. However, coronavirus disease 2019 patients with
elevated high sensitivity cardiac troponin measurements
reflecting acute cardiac injury will have more complex
management because the cardiac injury may be caused by
circulating cytokines from severe systemic inflammatory
stress, leading to atherosclerotic plaque instability and
rupture (type 1 acute myocardial infarction); caused by
increased myocardial demand from the infection, causing a
supply-demand mismatch (type 2 acute myocardial
infarction); or possibly caused by acute myocarditis caused
directly by the virus itself.4 Although coronavirus disease
2019 patients with acute cardiac injury have a worse clinical
prognosis,5 it will be more difficult to determine the exact
cause of the cardiac injury and hence what the optimal
therapeutic approach should be for each patient.
Ultimately, we, along with Chiang et al, believe that the
global implementation of a rapid high sensitivity cardiac
troponin algorithm for the assessment of patients with
possible acute myocardial infarction or cardiac injury will
result in optimal patient assessments and outcomes. Last,
the use of high sensitivity cardiac troponin in the ED is a
rapidly evolving field, and so alternative algorithms for the
rapid assessment of acute myocardial infarction in the ED
may soon be recommended.
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